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>65%, and even >80% in cases without metastasis. However, there are currently no effective treatments for patients with advanced RCC. Although the combined modality therapy is applied for cases with advanced stage cancer, the efficiency of conventional chemotherapy remains low.
Mutations or deletions in the tumor suppressor von HippelLindau gene (VHL) have been frequently observed in RCC. The VHL protein (pVHL)/E3 ubiquitin ligase complex targets hypoxia-inducible factor-1α (HIF-1α) for ubiquitin-proteasome-mediated degradation. 4, 5 Under normoxic conditions, HIF-1α is hydroxylated on critical proline residues by HIF prolyl hydroxylase (PHD), which requires oxygen, 2-oxoglutarate, and iron as cosubstrates. pVHL can then recognize and bind hydroxylated HIF-1α, enabling its ubiqui- Transforming growth factor-β (TGF-β) is the prototypic member of the TGF-β family. 6 At the cell surface, TGF-β binds to two kinase Although TGF-β is thought to act as both tumor-suppressive and tumor-promotive factor in a cell type-dependent method, little is known about the role of TGF-β in RCC. Thus, in the present study, the effect of TGF-β signaling on the progression of RCC was investigated by using histopathological examination and in vivo analyses. 
| MATERIAL S AND ME THODS

| Cell culture and reagents
| Lentiviral production and infection
We used a lentiviral vector system to overexpress specific genes as previously described. 7 For the overexpression of c-Ski or Noggin, complementary DNAs encoding human SKI or human NOG were inserted into pENTR201 with a multi-cloning site (pENTR201-MCS) empty vector and then transferred to a pCSII-EF-RfA destination vector by Gateway cloning technology (Thermo Fisher Scientific). 8 Introduction of luciferase and HA-tagged dominant-negative TGF-β type II receptor mutant (dnTβRII) was carried out as described previously. 9 pCSII-EF-GFP was used as positive control for lentiviral infection.
| Immunohistochemistry and TUNEL staining
Immunohistochemistry was carried out as previously described. 
| Immunoblotting
Immunoblotting was carried out as previously described. 10 Antibodies against c-Ski (#A303-518A; Bethyl Laboratories, Montgomery, TX, USA), Noggin (4C9; Sigma-Aldrich), and HA (3F10; Sigma-Aldrich)
were used as primary antibodies. Other primary antibodies and secondary antibodies were prepared as previously described. 
| Quantitative real-time reverse transcription-PCR analysis
Total RNA was extracted as previously described. 7 Complementary DNA was prepared from each cell and subjected to qRT-PCR analysis as previously described. 7 Primer sequences are described in Table S1 .
| Mouse renal orthotopic tumor models and bioluminescence imaging
Tumor-forming ability of ccRCC cells in mice was analyzed using mouse renal orthotopic tumor models and bioluminescence imaging as previously described. 11 All protocols were approved by the Animal Ethics Committee of the Graduate School of Medicine at The University of Tokyo. BALB/c-nu/nu male mice (5-weeks-old) were purchased from Sankyo Labo Service Corporation (Tokyo, Japan).
Firefly luciferase was introduced into ccRCC cells by infection of lentiviral vectors for bioluminescence imaging. 12 The ccRCC cells were resuspended in HBSS (Thermo Fisher Scientific) and then orthotopically injected into mouse kidney (3 × 10 4 Caki-1 cells or 3 × 10 4 OS-RC-2 cells in 50 μL per mouse, unless otherwise specified).
| Colony formation assay
Colony formation assay in soft agar was carried out as previously described. 12 Colony formation assay in detached culture was done using poly-2-hydroxyethyl methacrylate (HEMA; P3932; SigmaAldrich). Cells (1 × 10 5 ) were cultured in six-well plates precoated with poly-HEMA for 2 days.
| Statistical analysis
Statistical significance of the differences between experimental groups was estimated by using the F-test followed by the Student's or Welch's t test. All statistical analyses were conducted with a significance level of α = 0.05 (P < 0.05). Scatter diagrams were plotted using GraphPad Prism 6 (GraphPad Software).
| RE SULTS
| Elevated expression of c-Ski in ccRCC tissues
In order to examine whether TGF-β signaling pathway components are dysregulated in ccRCC, their expression levels in clinical tissues were analyzed using the Gene Expression Omnibus (GEO)
database. There were no significant differences in the expression levels of mRNAs encoding TGF-β receptors and Smads, including
and SMAD4, between ccRCC and corresponding normal renal tissues ( Figure 1 ). However, decreased expression of type III receptor (TGFBR3, also known as betaglycan) in ccRCC tissues was observed ( Figure 1 ), which was in agreement with our previous report. 11 In addition, we also found that the expression of mRNA encoding c- Table 1 ), suggesting that cancer cells begin expressing c-Ski during ccRCC progression. In the subsequent experiments, we focused on the role of c-Ski on tumor formation and TGF-β signaling in ccRCC cells.
| Tumor-promoting role of c-Ski during ccRCC progression
To 
| Tumor-suppressive effect of TGF-β on ccRCC progression
We hypothesized that c-Ski may promote tumorigenic activity of RCC cells by inhibiting Smad-dependent TGF-β signaling. To test this hypothesis directly, HA-tagged dnTβRII, the mutant receptor that lacks the intracellular domain, was introduced to OS-RC-2 cells.
Expression of dnTβRII and attenuation of TGF-β-induced phosphorylation of Smad2 were confirmed by immunoblotting ( Figure 4A ).
qRT-PCR also showed that the induction of SERPINE1 by TGF-β was impaired by the introduction of dnTβRII ( Figure 4B ). Then, we de- Figure 4) . Thus, we concluded that the attenuation of BMP signaling was less important for ccRCC than that of TGF-β signaling, and that c-Ski enhanced 
TA B L E 1 Expression of c-Ski in normal renal and clear cell renal carcinoma tissues
| Lack of the effect of TGF-β on angiogenesis in ccRCC
Because ccRCC is associated with HIF-1α hyperactivity, angiogenesis is an important factor for ccRCC development and progression. 
| Effect of TGF-β on the proliferation of ccRCC cells
Finally, direct effects of TGF-β on the survival of ccRCC cells were examined. TUNEL staining of tumor tissues showed that the number of apoptotic cells was less frequent in primary tumors derived from 
| D ISCUSS I ON
In the present study, the role of TGF-β signaling on RCC progression was investigated. Histopathological examinations showed that c-Ski expression was universally elevated in ccRCC tissues, suggesting that TGF-β signal transduction may be suppressed in ccRCC cells.
In vivo experiments showed that c-Ski overexpression promoted tumor formation, which was also replicated by the introduction of dnTβRII. Thus, we concluded that c-Ski suppressed TGF-β signaling in ccRCC cells, which, in turn, attenuated the tumor-suppressive role of TGF-β.
Many types of abnormalities in TGF-β signaling components have been identified in cancers. 14 In particular, alterations of Smad4 and TβRII, frequently observed in cancers, strongly attenuate TGF-β signaling. However, these observations have been mainly restricted to certain types of cancer, such as pancreatic Our previous research showed that overexpression of dnTβRII and c-Ski in human diffuse-type gastric carcinoma cells inhibited TGF-β signal transduction, which enhanced tumorigenesis in vivo through the potentiation of angiogenesis. 31, 32 Based on these observations, we examined whether a similar molecular mechanism was involved in ccRCC. Although inhibition of TGF-β signaling in F I G U R E 6 Induction of apoptosis of clear cell renal carcinoma (ccRCC) cells by transforming growth factor beta (TGF-β). A, Apoptosis in primary tumor tissues dissected from mice shown in Figure 4D , which were killed 3 wks after the transplantation. Left panels: tumor tissues were subjected to TUNEL staining. Representative images were captured for tissue from each mouse. Right panel: apoptosis was quantified by counting the number of TUNEL-positive cells in three independent fields; data represent the mean ± SD. *P < . 
